the hbsag prevalence among blood donors from eastern mediterranean and middle eastern countries: a systematic review and meta-analysis
Authors
abstract
results we included 66 eligible studies. the pooled prevalence of hbsag in blood donors of both emro and middle eastern (e and m) countries was 2.03% (95% confidence interval [ci]: 1.79 – 2.26). in addition, the prevalence rates in the emro countries was 1.99% (95% ci: 1.84 – 2.14) and 1.62% in the middle eastern countries (95% ci: 1.36 – 1.88). the prevalence among blood donors with more than one study was 1.58% in egypt, 0.58% in iran, 0.67% in iraq, 2.84% in pakistan, 3.02% in saudi arabia, 1.68% in turkey, and 5.05% in yemen. conclusions based on the who classification of hepatitis b virus (hbv) prevalence, the prevalence of hbsag in blood donors from e and m countries reached an intermediate level. however, there were low prevalence levels in some e and m countries. context the world health organization (who) recommends that all blood donations should be screened for evidence of infections, such as hepatitis b. the present study aimed to determine the prevalence of hepatitis b surface antigen (hbsag) in blood donors at the eastern mediterranean region office (emro) of the who and middle eastern countries. evidence acquisition a meta-analysis was carried out based on the results of an electronic literature search of pubmed, ovid, scopus, and google scholar for articles published from january 1, 2000, to august 31, 2015. in accordance with a significant homogeneity test and a large value of i2, the random effects model was used to aggregate data from the studies and produce the pooled estimates using the “metan” command.
similar resources
The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis.
CONTEXT The world health organization (WHO) recommends that all blood donations should be screened for evidence of infections, such as hepatitis B. The present study aimed to determine the prevalence of hepatitis B surface antigen (HBsAg) in blood donors at the eastern Mediterranean region office (EMRO) of the WHO and middle eastern countries. EVIDENCE ACQUISITION A meta-analysis was carried ...
full textprevalence of hbsag amongst healthy children in eastern mediterranean and middle eastern countries: a systematic review and meta-analysis
results we included 20 articles in our meta-analysis. the pooled hbsag prevalence in children of e and m countries was 2.73% (95% ci: %1.73% - 3.72%). the prevalence rates in the emro and middle eastern countries were 1.85% (95% ci: 1.27% - 2.43%) and 2.66% (95% ci: 1.31% - 4.01%), respectively. the prevalence rates amongst children in nations considered in more than one study were 0.81% (95% c...
full textPrevalence of asthma among Middle Eastern children: A systematic review
Background: The prevalence of asthma and allergy has increased during the last decades, especially in children. However, little is known about it in the Middle East region. This systematic review is aimed to estimate the prevalence of asthma among the Middle Eastern children. Methods: Local and international scientific databases including SID, Iranmedex, Medline and Science Direct were syste...
full textPrevalence of hepatitis A across various countries in the Middle East, African and Eastern European countries
full text
Prevalence of asthma among Middle Eastern children: A systematic review
Background: The prevalence of asthma and allergy has increased during the last decades, especially in children. However, little is known about it in the Middle East region. This systematic review is aimed to estimate the prevalence of asthma among the Middle Eastern children. Methods: Local and international scientific databases including SID, Iranmedex, Medline and Science Direct were systemat...
full textprevalence of hepatitis c virus genotypes among patients in countries of the eastern mediterranean regional office of who (emro): a systematic review and meta-analysis
conclusions the genotype distribution of hcv takes diverse patterns in emro countries. genotypes 1 and 3 were predominant in iran and pakistan, while genotype 4 and 1 were the most common genotypes in the middle east arab countries and north african arab countries. understanding the genotypes of hcv can help policy makers in designing good strategies for treatment. results a total of 563 record...
full textMy Resources
Save resource for easier access later
Journal title:
hepatitis monthlyجلد ۱۶، شماره ۳، صفحات ۰-۰
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023